Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update

Enrollment in CAReS Study in patients with cancer anorexia on track to deliver first data readout by calendar year-end
$10.0 Million of Cash and Cash Equivalents as of May 31, 2021
SOLANA BEACH, Calif., July 12, 2021 (GLOBE NEWSWIRE) — Artelo Biosciences,…

Click here to view the original article.